Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Not Good - Need PR

During the nine months ended February 29, 2008, TPL entered into licensing agreements with third parties, pursuant to which Phoenix Digital received aggregate proceeds of $48,851,970. During the nine months ended February 28, 2007, TPL entered into licensing agreements with third parties, pursuant to which Phoenix Digital received aggregate proceeds of $64,869,000. License proceeds of $2,920,000 relating to an additional license agreement signed in February 2007 were received in March 2007. Phoenix Digital recorded this amount as a license receivable.
I must be reading this incorrectly, right?
Share
New Message
Please login to post a reply